Pharmaceuticals, Biotechnology and Life Sciences
Bristol-Myers Squibb and PsiOxus Therapeutics have entered into an agreement granting Bristol-Myers Squibb exclusive worldwide rights to NG-348, a pre-clinical…
A French biopharmaceutical company Pharnext set to produce treatments to tackle neuropathy diseases, has completed patient enrollment for its international…
Novarits is expanding its ophthalmology pipeline as it secured the ownership of a US-based private company focused on treating long-sightedness.
Two phase III studies of two-drug HIV treatment regimen conducted by GSK’s HIV specialist ViiV Healthcare, Pfizer and Shinogi Limited,…
Biogen’s Board of Directors has appointed Michel Vounatsos as Chief Executive Officer and member of the Board of Directors, effective…
Silence Therapeutics and Quark Pharmaceuticals have settled in the arbitration regarding a milestone payment, as Silence is to receive a…
Novartis and Conatus Pharmaceuticals have signed a multipurpose deal which will help the two drug makers to make liver-disease treatment,…
Provexis has continued working with the University of Oslo undertaking further research into the relationship between Fruitflow – aheart-health functional…
GlaxoSmithKline and Innoviva have started a phase III study to compare certain triple combination asthma therapy with a double combination…
Vertex Pharmaceuticals Incorporated has reached a pricing and reimbursement agreement for Orkambi (lumacaftor/ivacaftor) with the German Federal Association of the…